Lenalidomide and Chronic Lymphocytic Leukemia

por González-Rodríguez, Ana Pilar, Payer, Angel R., Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Villa-Alvarez, Monica, Gonzalez-García, Esther, Gonzalez, Segundo
Publicado 2013

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia

por Sordo-Bahamonde, Christian, Lorenzo-Herrero, Seila, Gonzalez-Rodriguez, Ana P, R. Payer, Ángel, González-García, Esther, López-Soto, Alejandro, Gonzalez, Segundo
Publicado 2021

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia

por Sordo-Bahamonde, Christian, Lorenzo-Herrero, Seila, González-Rodríguez, Ana P., Payer, Ángel R., González-García, Esther, López-Soto, Alejandro, Gonzalez, Segundo
Publicado 2021

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

por Villa-Álvarez, Mónica, Sordo-Bahamonde, Christian, Lorenzo-Herrero, Seila, Gonzalez-Rodriguez, Ana P., Payer, Angel R., Gonzalez-Garcia, Esther, Villa-Álvarez, María C., López-Soto, Alejandro, Gonzalez, Segundo
Publicado 2018

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease

por Huergo-Zapico, Leticia, Acebes-Huerta, Andrea, Gonzalez-Rodriguez, Ana Pilar, Contesti, Juan, Gonzalez-García, Esther, Payer, Angel R., Villa-Alvarez, Monica, Fernández-Guizán, Azahara, López-Soto, Alejandro, Gonzalez, Segundo
Publicado 2014

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

por Sordo-Bahamonde, Christian, Lorenzo-Herrero, Seila, Martínez-Pérez, Alejandra, Gonzalez-Rodriguez, Ana P., Payer, Ángel R., González-García, Esther, Aguilar-García, Candelaria, González-Rodríguez, Sara, López-Soto, Alejandro, García-Torre, Alejandra, Gonzalez, Segundo
Publicado 2023

The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

por Lorenzo-Herrero, Seila, Sordo-Bahamonde, Christian, Bretones, Gabriel, Payer, Ángel R., González-Rodríguez, Ana P., González-García, Esther, Pérez-Escuredo, Jhudit, Villa-Álvarez, Mónica, Núñez, Luz-Elena, Morís, Francisco, Gonzalez, Segundo, López-Soto, Alejandro
Publicado 2019

Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma

por Cepeda-Piorno, Francisco-Javier, González-García, Esther, Méndez-Gallego, Alba, Torres-Varona, Juan, García-Moreira, Vanesa, Sordo-Bahamonde, Christian, AlberdiGarcía-del-Castillo, Cristina, Astobieta-Madariaga, Elene, Mateos-Manteca, Maria-Victoria, González-Rodríguez, Segundo
Publicado 2022

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

por Sancho, Juan‐Manuel, Fernández‐Alvarez, Rubén, Gual‐Capllonch, Francisco, González‐García, Esther, Grande, Carlos, Gutiérrez, Norma, Peñarrubia, María‐Jesús, Batlle‐López, Ana, González‐Barca, Eva, Guinea, José‐María, Gimeno, Eva, Peñalver, Francisco‐Javier, Fuertes, Miguel, Bastos, Mariana, Hernández‐Rivas, José‐Ángel, Moraleda, José‐María, García, Olga, Sorigué, Marc, Martin, Alejandro
Publicado 2021